Abstract
Although Alzheimer’s disease (AD) has become widely accepted as the most common cause of dementia in advanced age (1), the role of cerebrovascular disease (CVD) and ischemic brain lesions in cognitive decline remains controversial and confusing (2–5). Until the 1950 and 1960s, dementia in elderly subjects was usually labeled “atherosclerotic dementia,” although in 1919, Mingazzini (6) stated that this was the result of cerebral infarctions, similar to the concept stressed by Fisher (7). Tomlinson et al. (8) described the relationship between the volume of infarcted tissue and cognitive impairment, suggesting that destruction of large volumes of cortex may be necessarily followed by dementia, whereas subtle cerebrovascular lesions (CVLs) may or may not contribute to dementia, probably depending on their location. Hachinsky et al. (9) criticized the term “arteriosclerotic dementia” as both inaccurate and misleading and coined the term “multi-infarct dementia” (MID). Because MID constitutes only a small subdivision of all dementias of vascular etiology, the terms “vascular dementia” (VaD) (4,10–13), “cerebrovascular dementia” (14), “dementia associated with stroke” (15), or, more recently, “ischemic-vascular dementia” (16,17) “vascular-ischemic dementia” or “vascular cognitive impairment” (ViD) (18) were chosen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jorm AF. Epidemiology: meta-analysis. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 85–97.
Garcia JH, Brown GG. Vascular dementia: neuropathologic alterations and metabolic brain changes. J Neurol Sci 1992;109:121–131.
Munoz DG. The pathological basis of multi-infarct dementia. Alzheimer Dis Assoc Disord 1991;5:77–90.
Markesbery WR. Vascular dementia. In: Markesbery W, ed. Neuropathology of Dementing Disorders. London, UK: Arnold Publishers, 1998, pp. 293–311.
Mirra SS, Hyman BT. Vascular dementia. In: Graham D, Lantos P, eds. Greenfield’s Neuropathology. 7th Ed. London, UK: Arnold Publishing, 2002, pp. 241–245.
Mingazzini G. Anatomia clinica di centri nervosi. UTET, Torino 1913;548–573.
Fisher CM. Dementia in cerebral vascular disease. In: Toole J, Siekert R, Whisnant J, eds. Cerebral Vascular Disease. Sixth Princeton Conference. New York, NY: Greene and Stratton, 1968, pp. 232–236.
Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205–242.
Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974;2:207–210.
Mikol J. Vascular dementia. In: Duckett S, De la Torre JC, eds. Pathology of the Aging Human Nervous System, 2nd ed. New York, Oxford Univ. Press, 2001, pp. 101–122.
Esiri MM, Hyman BT, Beyreuther K, Masters CL. Vascular dementia. In: Graham D, Lantos P, eds. Greenfield’s Neuropathology. 6th Ed. London, UK: Arnold Publishing, 1997, pp. 204–210.
Leys D, Englund E, Erkinjuntti T. Vascular dementia. In: Qizilbash N, Schneider L, Brodaty H, Tariot P, Kaye J, Chui H, Erkinjuntti T, eds. Evidence Based Dementia Practice. Oxford, UK: Blackwell Science Publishing, 2002, pp. 260–287.
Markesbery WR. Overview of vascular dementia. In: Iqbal K, Sisodia S, Winblad B, eds. Alzheimer Disease: Advances in Etiology, Pathogenetics and Therapy. Paris, France: John Wiley & Sons, 2001, pp. 205–220.
Erkinjuntti T. Cerebrovascular dementia: pathophysiology, diagnosis and treatment. CNS Drugs 1999;12:35–18.
Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke 1997;28:459–63.
Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000;59:931–945.
Jellinger KA. The pathology of ischemic-vascular dementia: an update. J Neurol Sci 2002;203–204:153–157.
Jellinger KA. Vascular-ischemic dementia: an update. J Neural Transm 2002;(Suppl):1–23.
Moncayo J, Bogousslavski J. Vascular dementia: persisting controversies and questions. Eur J Neurol 1996;3:299–308.
Bowler JV, Hachinski V. Current criteria for vascular dementia-a critical appraisal. In: Bowler JV, Hachinski V, eds. Vascular Cognitive Impairment: Preventable Dementia. Oxford, Oxford Univ. Press, 2003, pp. 1–11.
Arvanitakis Z, Hachinski V. Vascular cognitive impairment: what else do we need to learn? In: Terry R, Katzman R, Bick K, Sisodia S, eds. Alzheimer Disease. 2nd Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999, pp. 147–160.
Hyman BT. New neuropathological criteria for Alzheimer disease. Arch Neurol 1998;55:1174–1176.
Jellinger KA. What is new in degenerative dementia disorders? Wien Klin Wochenschr 1999;111:682–704.
Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992;42:473–480.
Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
Knopman DS, Parisi JE, Boeve BF, et al. Vascular dementia in a population-based autopsy study. Arch Neurol 2003;60:569–575.
Goulding J, Signorini D, Chatterjee S, et al. Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry 1999;67:654–657.
Jellinger KA. Inverse correlation between cerebrovascular lesions and Braak stage (letter). J Neurol Neurosurg Psychiatry 2000;68:799–800.
Erkinjuntti T. Classification and criteria. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 99–113.
Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037–1044.
Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990;95:239–258.
Ulrich J, Probst A, Wuest M. The brain diseases causing senile dementia. A morphological study on 54 consecutive autopsy cases. J Neurol 1986;233:118–122.
Olsson Y, Brun A, Englund E. Fundamental pathological lesions in vascular dementia. Acta Neurol Scand Suppl 1996;168:31–38.
Pohjasvaara T, Mantyla R, Salonen O, et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000;57:1295–1300.
Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 1994;51:888–895.
Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995;152:1476–1484.
Moroney JT, Bagiella E, Desmond DW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997;49:1096–1105.
Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27:30–36.
Gertz HJ, Wolf H, Arendt T. [Vascular dementia]. Nervenarzt 2002;73:393–404.
Bowler JV, Munoz DG, Merskey H, Hachinski V. Fallacies in the pathological confirmation of the diagnosis of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1998;64:18–24.
Chui HC, Mack W, Jackson JE, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 2000;57:191–196.
Gold G, Giannakopoulos P, Montes-Paixao Junior C, et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690–694.
O’Brien MD. How does cerebrovascular disease cause dementia. Dementia 1994;5:133–136.
Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 2000;59(Suppl):23–30.
Gustafson I, Passant U. Clinical pathological correlates. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 85–97.
Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143–1153.
Englund E. White matter pathology in vascular dementia. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 77–84.
Englund E. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis 2002;13(Suppl):11–15.
Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci 2000;903:239–243.
Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H. Neuropathologic correlates of leuko-arabinosis. Arch Neurol 1989;46:1124–1128.
Pantoni L, Palumbo V, Sarti C. Pathological lesions in vascular dementia. Ann N Y Acad Sci 2002;977:279–291.
Rocca WA, Hofman A, Brayne C, et al. The prevalence of vascular dementia in Europe: facts and fragments from 1980–1990 studies. EURODEM-Prevalence Research Group. Ann Neurol 1991;30:817–824.
Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991;41:1886–1892.
Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology 1995;14:240–257.
Meyer JS, Rauch GM, Lechner H, Loeb C. Vascular Dementia. Armonk, NY: Futura Publishing, 2001, pp. 320.
Reed BR. Vascular dementia. Arch Neurol 2004;61:433–435.
Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002;203-204:7–10.
Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 2003;74:720–724.
Kase CS. Epidemiology of multi-infarct dementia. Alzheimer Dis Assoc Disord 1991;5:71–76.
Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S4–S9.
Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000;54:447–151.
Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 2000;31:1487–1493.
Hasegawa K, Homma A, Imai Y. An epidemiological study of age-related dementia in the community. Int J Geriatr Psychiatry 1986;l:94–105.
Li G, Shen YC, Chen CH, Zhau YW, Li SR, Lu M. A three-year follow-up study of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand 1991;83:99–104.
Ueda K, Kawano H, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992;23:798–803.
Yoshitake T, KiyO’Hara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161–1168.
Ikeda M, Hokoishi K, Maki N, et al. Increased prevalence of vascular dementia in Japan: a community-based epide-miological study. Neurology 2001;57:839–844.
Chiu HF, Lam LC, Chi I, et al. Prevalence of dementia in Chinese elderly in Hong Kong. Neurology 1998;50:1002–1009.
Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997;63:749–753.
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215–1222.
Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Incidence of vascular dementia in Rochester, MN, 1985–1989. Arch Neurol 2002;59:1605–1610.
Schneider JA, Wilson RS, Cochran EJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003;60:1082–1088.
Hulette C, Nochlin D, McKeel D, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 1997;48:668–672.
Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153–158.
Desmond DW, Moroney JT, Sano M, Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002;33:2254–2260.
Mirsen T, Hachinski V. The epidemiology and classification of vascular and multi-infarct dementia. In: Meyer J, Lechner H, Marshall J, Toole J, eds. Vascular and Multi-infarct Dementia. Mount Kisco, NY: Futura Publishing, 1988, pp. 61–76.
Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50% in nonagenarians. Arch Neurol 2000;57:713–719.
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813–817.
Corsellis JAN. Mental Illness and the Ageing Brain. London, UK: University Press, 1962.
Birkett DP. The psychiatric differentiation of senility and arteriosclerosis. Br J Psychiatry 1972;120:321–325.
Todorov AB, Go RC, Constantinidis J, Elston RC. Specificity of the clinical diagnosis of dementia. J Neurol Sci 1975;26:81–98.
Sourander P, Walinder J. Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease. Acta Neuropathol (Berl) 1977;39:247–254.
de Reuck J, Sieben G, de Coster W, vander Eecken H. Dementia and confusional state in patients with cerebral infarcts. A clinicopathological study. Eur Neurol 1982;21:94–97.
Mölsä PK, Paljarvi L, Rinne JO, Rinne UK, Sako E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48:1085–1090.
Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 1987;74:209–225.
Wade JP, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H. The clinical diagnosis of Alzheimer’s disease. Arch Neurol 1987;44:24–29.
Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer’s disease: autopsy results in 150 cases. Ann Neurol 1988;24:50–56.
Boiler F, Lopez OL, Moossy J. Diagnosis of dementia: clinicopathologic correlations. Neurology 1989;39:76–79.
del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia. A clinicopathological study. J Neurol Sci 1990;96:1–17.
Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994;5:145–147.
Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA. Neuropathological diagnoses in elderly patients in Oslo: Alzheimer’s disease, Lewy body disease, vascular lesions. Dementia 1995;6:162–168.
Bowler JV, Eliasziw M, Steenhuis R, et al. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Arch Neurol 1997;54:697–703.
Snowdon DA, Markesbery WR. The prevalence of neuropathologically confirmed vascular dementia: findings from the Nun study 1st Intern Congr on Vascular Dementia, Geneva, Switzerland, October 1999. Bologna, Italy: Monduzzi Editore S.p.A, 1999, pp. 19–24.
Nolan KA, Lino MM, Seligmann AW, Blass JP. Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc 1998;46:597–604.
Seno H, Ishino H, Inagaki T, Iijima M, Kaku K, Inata T. A neuropathological study of dementia in nursing homes over a 17-year period, in Shimane Prefecture, Japan. Gerontology 1999;45:44–48.
Akatsu H, Takahashi M, Matsukawa N, et al. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 2002;196:63–69.
Neuropathology G. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169–175.
Jellinger K, Mitter-Ferstl E. The impact of cerebrovascular lesions in Alzheimer disease. A comparative autopsy study. J Neurol 2003;250:1050–1055.
Loeb C. Neuropathological correlates of vascular dementia. In: Meyer J, Rauch G, Lechner H, Loeb C, Toole J, eds. Vascular Dementia. Armonk, NY: Futura Publishing, 2001, pp. 59–75.
Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138–143.
De Reuck J, De Reus R, De Koninck J. Sneddon’s syndrome. A not unusual cause of stroke in young women. In: Meyer J, Lechner H, Reivich M, Ott E, eds. Cerebral Vascular Disease. Amsterdam, The Netherlands: Excerpta Medica 6, 1987, pp. 171–174.
Marie P. Des foyers lacunaires de disintegration et de differents autres etats cavitaires du cerveau. Rev Med 1901;21:281–3298.
Fisher CM. Lacunes: small, deep cerebral infarcts. 1965. Neurology 1998;50:841–852.
Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982;32:871–876.
Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawa J. Ischemic stroke and incomplete infarction. Stroke 1995;27:761–765.
Poirier J, Derouesne C. Cerebral lacunae. A proposed new classification. Clin Neuropathol 1984;3:266.
Poirier J, Derouesne C. [The concept of cerebral lacunae from 1838 to the present]. Rev Neurol (Paris) 1985;141:3–17.
Tuszynski MH, Petito CK, Levy DE. Risk factors and clinical manifestations of pathologically verified lacunar infarctions. Stroke 1989:20:990–999.
Lassen NA. Incomplete cerebral infarction-focal incomplete ischemic tissue necrosis not leading to emollision. Stroke 1982;13:522–523.
Ma CK, Olsson Y. The role of chronic brain edema in the formation of lacunes in Binswanger’s encephalopathy. Histopathology and immunohistochemical observations. Cerebrovasc Dis 1997;7:324–331.
Lammie GA. Pathology of lacunar infarction. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcorti-cal Stroke. Oxford, UK: Oxford University Press, 2002, pp. 38–6.
Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002;12:358–370.
Derouesne C, Gray F, Escourelle R, Castaigne P. ‘Expanding cerebral lacunae’ in a hypertensive patient with normal pressure hydrocephalus. Neuropathol Appl Neurobiol 1987;13:309–320.
Pollock H, Hutchings M, Weller RO, Zhang ET. Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes. J Anat 1997;191:337–346.
Hughes W. Hypothesis—origin of lacunes. Lancet 1965;2:19–21.
Roman GC. Lagunas cerebrales. Estudio clínico y neurópatôlogico de 100 cases fatales. Rev Facultad Ciencias Medicas/Univ Nac Córdoba 1981;39:115–129.
De Reuck J, Van der Eecken H. The topography of infarcts in the lacunar state. In: Meyer J, Lechner H, Reivich M, eds. Cerebral Vascular Disease 7. Stuttgart, Germany: Thieme, 1976, pp. 162–165.
Pullicino PM. Pathogenesis of lacunar infarcts and small deep infarcts. Adv Neurol 1993;62:125–140.
Leys D, Bogousslavsky J. Mechanisms of vascular dementia. In: Leys D, Scheltens P, eds. Current Issues in Neurodegenerative Diseases. Vol. 6: Vascular Dementia. Amsterdam, The Netherlands: ICG, 1994, pp. 121–132.
Benson DF, Cummings JL. Angular gyrus syndrome simulating Alzheimer’s disease. Arch Neurol 1982;39:616–620.
Zekry D, Duyckaerts C, Belmin J, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging 2003;24:213–219.
Castaigne P, Lhermitte F, Buge A, Escourolle R, Hauw JJ, Lyon-Caen O. Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol 1981;10:127–148.
de Freitas GR, Bogousslavsky J. Thalamic infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. 2nd Ed. Oxford, UK: Oxford University Press, 2002, pp. 255–285.
Szirmai I, Vastagh I, Szombathelyi E, Kamondi A. Strategic infarcts of the thalamus in vascular dementia. J Neurol Sci 2002;203—204:91–97.
Brion S, Pragier G, Guerin R, Teitgen M. Syndrome de Korsakoff par ramollissement bilateral du fornix. Rev Neurol 1969;120:255–262.
Escourolle R, Gray F. Les accidents vasculaires du systeme limbique 7th Congr Neuropathol Budapest. Amsterdam, The Netherlands: Excerpta Medica, 1975.
Glees P, Griffith GH. Bilateral destruction of the hippocampus in case of dementia. Monatsschr Psych Neurol 1953;123:193–204.
Caplan LR. Binswanger’s disease—revisited. Neurology 1995;45:626–633.
Caplan LR, Helgason CM. Caudate infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Lacunar and Other Subcortical Infarctions. Oxford, UK: Oxford University Press, 1995, pp. 117–130.
de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145–151.
de Leeuw FE, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765–772.
Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm Suppl 1998;53:31–39.
Hentschel F, Kreis M, Damian M, Krumm B. [Microangiopathic lesions of white matter. Quantitation of cerebral MRI findings and correlation with psychological tests], Nervenarzt 2003;74:355–361.
Ward NS, Brown MM. Leukoariosis. In: Cummings JL, ed. Subcortical Dementia. Oxford, UK: Oxford University Press, 1990, pp. 47–68.
Binswanger O. Die Abgrenzung der allgemeinen progressiven Paralyse. Berliner Klin Wochenschr 1894;31:1103–1105, 1137–1139, 1180–1186.
Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21–23.
Babikian V, Ropper AH. Binswanger’s disease: a review. Stroke 1987;18:2–12.
Blass JP, Hoyer S, Nitsch R. A translation of Otto Binswanger’s article, ‘The delineation of the generalized progressive paralyses’. 1894. Arch Neurol 1991;48:961–972.
Brun A, Fredriksson K, Gustafson L. Pure subcortical arteriosclerotic encephalopathy (Binswanger’s disease): a clini-copathological study. Part I: pathological features. Cerebrovasc Dis 1992;2:87–92.
Fisher CM. Binswanger’s encephalopathy: a review. J Neurol 1989;236:65–79.
Jellinger K, Neumayer E. Progressive subcortical Encephalopathie Binswanger. Eine klinisch-neuropathologische Studie. Arch Psych Z Ges Neurologie 1964;205:523–554.
Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review. Stroke 1995;26:1293–1301.
Van de Nes JAP, Zimmer R, Janzen RWC, Turowski B, Hurtle E, Schlote W. Mini-infarct encephalopathy associated with uncommon microvessel convolute formation presenting with presenile dementia. Clin Neuropathol 2003;22:101–109.
Grafton ST, Sumi SM, Stimac GK, Alvord EC, Jr., Shaw CM, Nochlin D. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. Arch Neurol 1991;48:293–298.
van Swieten JC, Geyskes GG, Derix MM, et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 1991;30:825–830.
Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002;13:7–10.
Wakita H, Tomimoto H, Akiguchi I, et al. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 2002;924:63–70.
Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoariosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol 1990;11:273–281.
Brown MM, Pelz DM, Hachinski VC. White matter vasodilatory reserve is impaired in patients with cerebrovascular disease and diffuse periventricular lacunes. J Neurol 1990;237:157.
Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994;25:375–381.
Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Arch Neurol 1995;52:773–780.
Kwan LT, Reed BR, Eberling JL, et al. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol 1999;56:809–814.
Yoshikawa T, Murase K, Oku N, et al. Quantification of the heterogeneity of cerebral blood flow in vascular dementia. J Neurol 2003;250:194–200.
Yoshikawa T, Murase K, Oku N, et al. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessel disease. J Nucl Med 2003;44:505–511.
DeReuck J, Schaumburg HH. Periventricular atherosclerotic leukoencephalopathy. Neurology 1972;22:1094–1097.
Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol 1990;11:431–439.
Mayer PL, Kier EL. The controversy of the periventricular white matter circulation: a review of the anatomic literature. AJNR Am J Neuroradiol 1991;12:223–228.
Feigin L, Poport N. Neuropathological changes late in cerebral edema. The relationship to trauma, hypertensive disease and Binswanger’s encephalopathy. J Neuropathol Exp Neurol 1963;22:500–511.
Kirkpatrick JB, Hayman LA. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis. Radiology 1987;162:509–511.
Salahuddin TS, Johansson BB, Kalimo H, Olsson Y. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: a light microscopic and immunohistochemical study. Neuropathol Appl Neurobiol 1988;14:467–482.
De Reuck J. Neuropathology of vascular dementia. In: Leys D, Scheltens P, eds. Current Issues in Neurodegenerative Diseases. Vol. 6: Amsterdam, The Netherlands: Vascular Dementia. ICG, 1994, pp. 9–15.
Chabriat H, Bousser MG. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. 2nd Ed. Oxford, UK: Oxford University Press, 2002, pp. 116–126.
Filley CM, Thompson LL, Sze CI, Simon JA, Paskavitz JF, Kleinschmidt-DeMasters BK. White matter dementia in CADASIL. J Neurol Sci 1999;163:163–167.
Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 2002;12:371–384.
Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985;18:54–59.
Tomimoto H, Akiguchi I, Akiyama H, et al. Vascular changes in white matter lesions of Alzheimer’s disease. Acta Neuropathol (Berl) 1999;97:629–634.
Waxman SG. Molecular mechanisms of subcortical versus cortical infarction. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. Oxford, UK: Oxford University Press, 2002, pp. 67–83.
Brown WR, Moody DM, Thore CR, Challa VR. Apoptosis in leukoaraiosis. AJNR Am J Neuroradiol 2000;21:79–82.
Hanyu H, Tanaka Y, Shimizu S, et al. Cerebral microbleeds in Binswanger’s disease: a gradient-echo T2*-weighted magnetic resonance imaging study. Neurosci Lett 2003;340:213–216.
Loeb C. Binswanger’s disease is not a single entity. Neurol Sci 2000;21:343–348.
Tanoi Y, Okeda R, Budka H. Binswanger’s encephalopathy: serial sections and morphometry of the cerebral arteries. Acta Neuropathol (Berl) 2000;100:347–355.
Tomimoto H, Akiguchi I, Wakita H, Kimura J. [Changes in glial cells in Binswanger-type infarction]. No To Shinkei 1994;46:771–779.
Zhang WW, Badonic T, Hoog A, et al. Structural and vasoactive factors influencing intracerebral arterioles in cases of vascular dementia and other cerebrovascular disease: a review. Immunohistochemical studies on expression of col-lagens, basal lamina components and endothelin-1. Dementia 1994;5:153–162.
Yamanouchi H. Loss of white matter oligodendrocytes and astrocytes in progressive subcortical vascular encephalopathy of Binswanger type. Acta Neurol Scand 1991;83:301–305.
Zambenedetti P, Schmitt HP, Zatta P. Metallothionein I-II immunocytochemical reactivity in Binswanger’s encephalopathy. J Alzheimers Dis 2002;4:459–466.
Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2002;72:217–220.
Zhan SS, Beyreuther K, Schmitt HP. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. Dementia 1994;5:79–87.
Fein G, Di Sclafani V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626–1635.
Mungas D, Jagust WJ, Reed BR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 2001;57:2229–2235.
Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979;36:65–73.
Wardlaw JM, Dennis MS, Warlow CP, Sandercock PA. Imaging appearance of the symptomatic perforating artery in patients with lacunar infarction: occlusion or other vascular pathology? Ann Neurol 2001;50:208–215.
Van der Eecken H. Anastomoses between the leptomeningeal arteries of the brain. Springfield, IL: Charles C. Thomas, 1959.
Paulson GW, Kapp J, Cook W. Dementia associated with bilateral carotid artery disease. Geriatrics 1966;21:159–166.
Torvik A. The pathogenesis of watershed infarcts in the brain. Stroke 1984;15:221–223.
Dickson DW. Neuropathology of Alzheimer’s disease and other dementias. Clin Geriatr Med 2001;17:209–228.
Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (>or = 80 years of age) humans. Acta Neuropathol (Berl) 1994;88:212–221.
Jellinger KA. Hippocampal sclerosis: a common pathological feature of dementia in very old humans. Acta Neuropathol (Berl) 1994;88:599.
Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Severity of vascular dementia is related to volume of metaboli-cally impaired tissue. Arch Neurol 1992;49:909–913.
Erkinjuntti T, Benavente O, Eliasziw M, et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 1996;53:325–332.
Basso A, Capitani E, Luzzatti C, Spinnler H. Intelligence and left hemisphere disease. The role of aphasia, apraxia and size of lesion. Brain 1981;104:721–734.
Cummings JL, Benson DF. Psychological dysfunction accompanying subcortical dementias. Annu Rev Med 1988;39:53–61.
Tatemichi TK, Sacktor N, Mayeux R. Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terr RD, Katzman R, Bick KL, eds. Alzheimer’s Disease. New York, NY: Raven Press, 1994, pp. 123–166.
Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859–876.
Caplan LR. Caudate infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. 2nd Ed. Oxford, UK: Oxford University Press, 2002, pp. 208–223.
Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia. A clinical and brain imaging experience. Arzneimittelforschung 1995;45:371–385.
Tatemichi TK, Desmond DW, Prohovnik I, et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 1992;42:1966–1979.
Du AT, Schuff N, Laakso MP, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002;58:1635–1641.
Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 2002;72:747–751.
Cordoliani-Mackowiak MA, Henon H, Pruvo JP, Pasquier F, Leys D. Poststroke dementia: influence of hippocampal atrophy. Arch Neurol 2003;60:585–590.
Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 1991;41:479–486.
McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia withLewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–1124.
Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413–126.
Fearnley JM, Lees AJ. Pathology of Parkinson disease. In: Calne D, ed. Neurodegenerative Diseases. Philadelphia, PA: WB Saunders, 1994, pp. 545–554.
Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003;62:885–898.
Vinters HV, Farag ES. Amyloidosis of cerebral arteries. In: Barnett HJM, Bogousslavsky J, Meldrum H, eds. Ischemic Stroke: Advances in Neurology, Vol. 92. Philadelphia, PA: Lippincott Williams & Wilkins, 2003, pp. 105–120.
Thai DR, Ghebremedhin E, Rub U, Yamaguchi H, Tredici KD, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2002;61:282–293.
Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E e2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998;50:961–965.
Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993;116:135–141.
Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002;109:813–836.
Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 1988;19:205–210.
Scholz W. Studien zur Pathologie der Hirngefasse II: Die drusige Entartung der Hirnarterien und Capillaren. Z Ges Neurol Psychiat 1938;162:694–715.
Tomonaga M. Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 1981;29:151–157.
Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983;14:924–928.
Yoshimura M, Yamanouchi H, Kuzuhara S, et al. Dementia in cerebral amyloid angiopathy: a clinicopathological study. J Neurol 1992;239:441–450.
Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987;234:371–376.
Bergeron C, Ranalli PJ, Miceli PN. Amyloid angiopathy in Alzheimer’s disease. Can J Neurol Sci 1987;14:564–569.
Ellis RJ, Olichney JM, Thai LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 1996;46:1592–1596.
Esiri MM, Wilcock GK. Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 1986;49:1221–1226.
Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP, Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991;30:637–649.
Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S115–S123.
Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog Neurobiol 2001;64:575–611.
Olichney JM, Ellis RJ, Katzman R, Sabbagh MN, Hansen L. Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer’s disease. Ann N Y Acad Sci 1997;826:493–497.
Kalaria RN. The role of cerebral ischemia in Alzheimer’s disease. Neurobiol Aging 2000;21:321–330.
Lee SS, Stemmermann GN. Congophilic angiopathy and cerebral hemorrhage. Arch Pathol Lab Med 1978;102:317–321.
Ishii N, Nishihara Y, Horie A. Amyloid angiopathy and lobar cerebral haemorrhage. J Neurol Neurosurg Psychiatry 1984;47:1203–1210.
Feldmann E, Tornabene J. Diagnosis and treatment of cerebral amyloid angiopathy. Clin Geriatr Med 1991;7:617–630.
Hill MD, Silver FL, Austin PC, Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 2000;31:123–127.
Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thai LJ. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E epsilon4. Arch Neurol 2000;57:869–874.
Cadavid D, Mena H, Koeller K, Frommelt RA. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 2000;59:768–773.
Tabaton M, Caponnetto C, Mancardi G, Loeb C. Amyloid beta protein deposition in brains from elderly subjects with leukoariosis. J Neurol Sci 1991;106:123–127.
Wattendorff AR, Frangione B, Luyendijk W, Bots GT. Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J Neurol Neurosurg Psychiatry 1995;58:699–705.
Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697–705.
Abrahamson M, Jonsdottir S, Olafsson I, Jensson O, Grubb A. Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 1992;89:377–380.
Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992;1:218–221.
Tagliavini F, Rossi G, Padovani A, et al. A new pPP mutationrelated to hereditary cerebral hemorrhage. Alz Reports 1999;2:S28.
Nilsberth C, Westlind-Danielsson A, Eckman CB, et al. The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation. Nat Neurosci 2001;4:887–893.
Wang Z, Natte R, Berliner JA, van Duinen SG, Vinters HV. Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke 2000;31:534–538.
Levy E, Sastre M, Kumar A, et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 2001;60:94–104.
Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001;50:765–772.
Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996;148:351–354.
Blevins G, Macaulay R, Harder S, et al. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003;60:1625–1630.
Haltia M, Ghiso J, Prelli F, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 1990;136:1223–1228.
Kiuru S, Salonen O, Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol 1999;45:305–311.
Mayer M, Straube A, Bruening R, et al. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol 1999;246:526–532.
Yousry TA, Seelos K, Mayer M, et al. Characteristic MR lesion pattern and correlation of Tl and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol 1999;20:91–100.
Vidal R, Frangione B, Rostagno A, et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999;399:776–781.
Vidal R, Revesz T, Rostagno A, et al. A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 2000;97:4920–1925.
Holton JL, Lashley T, Ghiso J, et al. Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 2002;61:254–267.
Tohgi H, Abe T, Kimura M, Saheki M, Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 1996;103:1211–1220.
Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology 2003;60.
Oldfors A, Fyhr IM, Holme E, Larsson NG, Tulinius M. Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol (Berl) 1990;80:541–546.
Powers JM, DeVivo DC. Peroxismal and mitochondrial disorders. In: Graham D, Lantos P, eds. Greenfield’s Neuropathology. 7th Ed. London, UK: Arnold Publishing, 2002, pp. 737–797.
Muller-Hocker J, Hubner G, Bise K, et al. Generalized mitochondrial microangiopathy and vascular cytochrome c oxidase deficiency. Occurrence in a case of MELAS syndrome with mitochondrial cardiomyopathy-myopathy and combined complex I/IV deficiency. Arch Pathol Lab Med 1993;117:202–210.
Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993;52:1–10.
Ohama E, O’Hara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol (Berl) 1987;74:226–233.
Love S, Hilton DA. Assessment of the distribution of mitochondrial ribosomal RNA in melas and in thrombotic cerebral infarcts by in situ hybridization. J Pathol 1996;178:182–189.
Bowler J, Hachinski V. Vascular dementia. In: Ginsberg M, Bogousslavsky J, eds. Cerebrovascular disease. II: Patho-physiology, Diagnosis and Management. Oxford, UK: Blackwell Science, 1998, pp. 1126–1144.
Kaye JA. Diagnostic challenges in dementia. Neurology 1998;51:S45–S52; discussion S65–7.
Mendez MF, Mastri AR, Sung JH, Frey WH. Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord 1992;6:35–43.
Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet 1999;354:919–920.
Katzman R, Brown T, Thai LJ, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer’s disease. Ann Neurol 1988;24:384–389.
Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thai LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 2000;57:1474–1479.
O’Brien KD, Olin KL, Alpers CE, et al. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 1998;98:519–527.
Cohen CI, Araujo L, Guerrier R, Henry KA. “Mixed dementia”: adequate or antiquated? A critical review. Am J Geriatr Psychiatry 1997;5:279–283.
Rockwood K. Lessons from mixed dementia. Int Psychogeriatr 1997;9:245–249.
O’Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988;45:797–798.
Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer disease: a postmortem study. Acta Neuropathol 2003;105:14–17.
Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in Alzheimer Disease. J Neuropathol Exp Neurol 1997;56:165–170.
Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), Part X: Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 1995;45:461–466.
Crystal H, Dickson D. Cerebral infarcts in patients with autopsy proven Alzheimer’s disease (abstract). Neurobiol Aging 2002;23:207.
Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer’s disease: a postmortem study. Acta Neuropathol (Berl) 2003;105:14–17.
Fayet G, Hauw JJ, Delaere P, et al. Neuropathology of 20 centenarians. I: Clinical data. Rev Neurol 1994;150:16–21.
Giannakopoulos P, Hof PR, Surini M, Michel JP, Bouras C. Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol 1993;85:602–610.
Mizutani T, Shimada H. Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 1992;108:168–177.
Aliev G, Smith MA, Seyidov D, et al. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer’s disease. Brain Pathol 2002;12:21–35.
De La Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152–1162.
Grammas P, Moore P, Weigel PH. Microvessels from Alzheimer’s disease brains kill neurons in vitro. Am J Pathol 1999;154:337–342.
Sparks DL. Coronary artery disease: hypertension, ApoE, and cholesterol: a link to Alzheimer’s disease? Ann NY Acad Sci 1997;826:128–146.
Sparks DL, Hunsaker JC, 3rd, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR. Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease. Neurobiol Aging 1990;11:601–607.
Kovari E, Gold G, Herrmann FR, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004;35:410–414.
Corbett A, Bennett H, Kos S. Cognitive dysfunction following subcortical infarction. Arch Neurol 1994;51:999–1007.
Heyman A, Fillenbaum G, Welsh-Bohmer K, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease, CERAD, Part XVIII (abstract). Neurology 1998,51:159–162.
Frisoni GB, Geroldi C. Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease. Arch Neurol 2001;58:1939–1940.
Brun A. Neuropathology of cerebrovascular lesions in dementia. Seventh International Conference on Alzheimer’s Disease and Related Disorders. Neurobiol Aging 2000;21:S7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Jellinger, K.A. (2005). The Neuropathologic Substrates of Vascular-Ischemic Dementia. In: Paul, R.H., Cohen, R., Ott, B.R., Salloway, S. (eds) Vascular Dementia. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-824-2:023
Download citation
DOI: https://doi.org/10.1385/1-59259-824-2:023
Publisher Name: Humana Press
Print ISBN: 978-1-58829-366-4
Online ISBN: 978-1-59259-824-3
eBook Packages: MedicineMedicine (R0)